Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy

Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy

Source: 
Xconomy
snippet: 

Nearly nine years ago Jeanne Loring and her colleagues at Scripps Research debuted a test that leveraged advances in genomics and data science to determine, without testing in animals, whether human stem cells were “pluripotent,” or able to become any type of cell in the body.